Back to search

Article

The superoxide dismutase mimetic GC4419 enhances tumor killing when combined with stereotactic ablative radiation

2020-03-11

Abstract excerpt

The penta-aza macrocyclic manganese compound GC4419 is in phase 3 clinical trials as a modifier of mucositis in H&N cancer treated by radio-chemotherapy based upon its properties as a superoxide dismutase mimetic. In studies to address the potential for tumor radioprotection, a significant anti-tumor effect was identified in tumors generated from the non-small cell lung cancer (NSCLC) cell line H1299, when GC4419...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad2b39b8-143a-5139-93e3-8c5513f9d928
DOI
10.1101/2020.03.10.984443
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The superoxide dismutase mimetic GC4419 enhances tumor killing when combined with stereotactic ablative radiationDOI 10.1101/2020.03.10.984443
Select a neighboring publication to make it the new centre.